News

BME Researcher Wins SIAM/AWM Award

By: 

Esmeralda Fisher

Cheryl Sershen, Ph.D., received an Association for Women in Mathematics (AWM) travel award and presented her research at the Society for Industrial and Applied Mathematics (SIAM) conference in July. Her work is titled Dynamic Model of DNA Structure and Function.

Sershen is a post-doctoral researcher in associate professor Elebeoba May’s group. Sershen’s research interests include large-scale simulation in the modeling of biological systems such as kinetic, Monte Carlo, non-equilibrium modeling of stressed-induced duplex destabilization in DNA, development of multi-scale models to portray host-pathogen interactions like those of Mycobacterium tuberculosis and Francisella tularensis, agent based modeling and dynamical systems, and large scale bioinformatics studies of diseases like cancer and autism.

Sershen received her Ph.D. from the University of California at Davis in 2009.  She received an M.S. in mathematics from Stanford University in 2001 and an M.S. in engineering from Columbia University in 1996. In her previous work, she was a postdoctoral researcher at the U.C. Davis Genome Center and bioinformatics researcher at the Baylor College of Medicine.

Faculty: 

Department: 

Related News Stories

Class of 2020 honored with virtual graduation celebration

Michelle Gale.

The fortitude of the Cullen College of Engineering's Class of 2020 was proudly celebrated by the university community on May 7, with a 90-minute virtual graduation celebration, featuring remarks from University of Houston leadership, a commencement speaker and most importantly, the graduating students.

Shevkoplyas's Research Seeks New Way to Separate T-Cells

Sergey Shevkoplyas, associate professor of biomedical engineering.

Doors could soon open wider for cell-based therapies, thanks to research underway in the University of Houston lab of Dr. Sergey Shevkoplyas, associate professor of biomedical engineering.

With funding from a Cancer Prevention & Research Institute of Texas grant, Shevkoplyas and his research team are seeking to revolutionize the first step in a patient’s individualized cell-based treatment: the harvesting of T-cells from the patient’s blood.

Upcoming Events / Seminars